← Back to headlines
Atara Biotherapeutics Stock Jumps on FDA Cell Therapy Report
Shares of Atara Biotherapeutics surged following reports of a potential U-turn by the FDA regarding its cell therapy.
25 Feb, 18:56 — 25 Feb, 18:56
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Solon: Study-for-work for med-tech students can solve manpower woes
just now
Plzeň Hospital Offers Free Vitamin D Testing in March
18m ago
Zakynthos: Mother of baby with meningitis claims pediatrician called in sick; positive updates on baby's health
23m ago
Christina Applegate Shares Struggles with MS and Motherhood
28m ago